The paediatric cell therapy and bone marrow transplant programme at Texas Children's Hospital in Houston, treating children with blood, immune and metabolic disorders.
The site describes a paediatric cell therapy and bone marrow transplant programme within Texas Children's Hospital in Houston. It is a hospital department rather than a private regenerative medicine clinic, and the treatments described are blood and marrow transplants and cell and gene therapy infusions for children with serious disease.
According to the hospital, the programme was founded in 1997 and carries out more than 140 transplants and cell or gene therapy infusions a year. It states that both autologous transplants, using the child's own blood-forming cells, and allogeneic transplants, using cells from a donor, are performed, and that the programme offers gene therapies for sickle cell disease, thalassaemia and certain metabolic disorders. The site says some cell products are manufactured in house.
The hospital states that the programme has been accredited by the Foundation for the Accreditation of Cellular Therapy since 2002, and that its inpatient transplant unit has 25 beds, which it describes as the largest of its kind in the south-western United States. These are the hospital's own statements and have not been independently checked.
The departmental page names sub-programmes for immune disorders, haemoglobin disorders such as sickle cell disease and thalassaemia, and neurometabolic disorders, as well as care for graft-versus-host disease and kidney complications after transplant. It directs readers to a separate page to meet the team and does not name a director on the page itself.
The departmental page names the following groups of childhood conditions treated by the programme.
The site says the programme infuses blood-forming stem cells, from the child or from a donor, and also gives gene-modified cell therapies, some of which it prepares in its own facility.
The departmental page does not name individual clinicians; it refers readers to a separate page to meet the team.
The site places the programme at Texas Children's Hospital on Fannin Street in Houston, in the Wallace Tower. It describes a 25-bed inpatient transplant unit, which the hospital calls the largest of its kind in the south-western United States, and states that the programme has held accreditation from the Foundation for the Accreditation of Cellular Therapy since 2002.
The departmental page says nothing about the cost of treatment or about insurance.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.